Showing results (21-30 of 129) with videos related to
Sort By:
Pageof 13
Frontiers in Immunology|January 23, 2024
Vdelta1 T cells are more resistant than Vdelta2 T cells to the immunosuppressive properties of galectin-3Jan Schadeck, Hans-Heinrich Oberg, Matthias Peipp, et al.Oncotarget|September 23, 2015
HER2-specific immunoligands engaging NKp30 or NKp80 trigger NK-cell-mediated lysis of tumor cells and enhance antibody-dependent cell-mediated cytotoxicityMatthias Peipp, Stefanie Derer, Stefan Lohse, et al.Frontiers in Immunology|January 28, 2021
Complement-Dependent Activity of CD20-Specific IgG Correlates With Bivalent Antigen Binding and C1q Binding StrengthSina Bondza, Anita Marosan, Sibel Kara, et al.Journal of Immunological Methods|February 22, 2015
The novel multispecies Fc-specific Pseudomonas exotoxin A fusion protein α-Fc-ETA' enables screening of antibodies for immunotoxin developmentKatja Klausz, Christian Kellner, Stefanie Derer, et al.Journal of Immunological Methods|February 26, 2004
Efficient eukaryotic expression of fluorescent scFv fusion proteins directed against CD antigens for FACS applicationsMatthias Peipp, Domenica Saul, Karin Barbin, et al.Frontiers in Immunology|July 23, 2020
Galectin-3 Released by Pancreatic Ductal Adenocarcinoma Suppresses γδ T Cell Proliferation but Not Their CytotoxicityDaniel Gonnermann, Hans-Heinrich Oberg, Marcus Lettau, et al.Biochemical and Biophysical Research Communications|June 15, 2004
Susceptibility to SARS coronavirus S protein-driven infection correlates with expression of angiotensin converting enzyme 2 and infection can be blocked by soluble receptorHeike Hofmann, Martina Geier, Andrea Marzi, et al.Cellular Immunology|May 17, 2015
γδ T cell activation by bispecific antibodiesHans-Heinrich Oberg, Christian Kellner, Daniel Gonnermann, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 27, 2012
Impact of epidermal growth factor receptor (EGFR) cell surface expression levels on effector mechanisms of EGFR antibodiesStefanie Derer, Philip Bauer, Stefan Lohse, et al.Methods in Molecular Biology (Clifton, N.J.)|September 10, 2018
Fc Glyco- and Fc Protein-Engineering: Design of Antibody Variants with Improved ADCC and CDC ActivityChristian Kellner, Stefanie Derer, Katja Klausz, et al.Pageof 13